Richard D. Sloan
- Virology top 0.5%
- Infectious Diseases top 2%
- Molecular Biology
- Immunology top 10%
- Epidemiology top 10%
- Co-authors
- Mark A. WainbergDaniel A. DonahueBjörn D. KuhlTamara Bar-MagenHongtao XuPeter K. QuashieJordan S. TaylorEugene L. Asahchop
- Topics
- HIV Research and Treatment (28 papers)HIV/AIDS drug development and treatment (16 papers)Biochemical and Molecular Research (6 papers)
- Partner nations
- CanadaUnited KingdomChina
In The Last Decade
Richard D. Sloan
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 76
- Virology 785
- Infectious Diseases 650
- Molecular Biology 377
- Immunology 292
- Epidemiology 278
Countries citing papers authored by Richard D. Sloan
This map shows the geographic impact of Richard D. Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Sloan more than expected).
Fields of papers citing papers by Richard D. Sloan
This network shows the impact of papers produced by Richard D. Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Sloan. The network helps show where Richard D. Sloan may publish in the future.
Co-authorship network of co-authors of Richard D. Sloan
This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Sloan. A scholar is included among the top collaborators of Richard D. Sloan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Sloan. Richard D. Sloan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 63 | |
| 5 | 26 | |
| 6 | 12 | |
| 7 | 51 | |
| 8 | 4 | |
| 9 | 9 | |
| 10 | 57 | |
| 11 | 111 | |
| 12 | 20 | |
| 13 | 7 | |
| 14 | 14 | |
| 15 | 82 | |
| 16 | 52 | |
| 17 | 31 | |
| 18 | 25 | |
| 19 | 40 | |
| 20 | 18 |
About Richard D. Sloan
Richard D. Sloan is a scholar working on Virology, Infectious Diseases and Immunology, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (16 papers) and Biochemical and Molecular Research (6 papers). The work is most often cited by research in Virology (785 citations), Infectious Diseases (650 citations) and Immunology (292 citations). Richard D. Sloan has collaborated with scholars based in Canada, United Kingdom and China. Frequent co-authors include Mark A. Wainberg, Daniel A. Donahue, Björn D. Kuhl, Tamara Bar-Magen, Hongtao Xu, Peter K. Quashie, Jordan S. Taylor, Eugene L. Asahchop, Cécile Tremblay and Maureen Oliveira. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.